FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892070531> ?p ?o ?g. }

• W2892070531 endingPage "9" @default.
• W2892070531 startingPage "9" @default.
• W2892070531 abstract "Objective: Nasal delivery provides a route of entry of drug to the brain that circumvents the obstacle for blood-brain barrier allowing direct drug delivery to the central nervous system via olfactory neurons. The objective of work was to prepare solid lipid nanoparticles of antimalarial drug artemether for brain delivery through olfactory delivery route for treatment of cerebral malaria.Methods: Artemether containing solid lipid nanoparticles were prepared with soya lecithin and poloxamer 407 with a hot homogenization method followed by solvent injection technique. The prepared solid lipid nanoparticles were characterized by their shape, particle size, zeta potential, encapsulation efficiency total drug content and drug release study.Results: These solid lipid nanoparticles were observed spherical in shape in scanning electron microscopy, the optimized size was found to be 211.6 nm (Polydispersity Index PI<0.415), with −27mV zeta potential value. The maximum % yield of the formulation was found to be found 49%. The maximum entrapment efficiency was 82% (w/w), and optimized formulation showed 98.07±1.521% drug release form formulation. In vivo studied were conducted on wistar rats after administration of artemether containing solid lipid nanoparticles intranasally and compared with plain artemether solution administered orally. The results of optimized formulation showed the value of biological half-life (T1/2) was 4.95 h, maximum serum concentration Cmax was 644.60ng/ml, time for drug to reach peak plasma concentration Tmax was 1 h volume of distribution (Vd) was 2.7l/kg, body clearance (Cl) was 0.37 lh/kg and Area under curve [AUC]0∞ was 3970.5 nghr/ml for formulation.Conclusion: The results revealed that the brain: plasma concentration ratio was higher after intranasal administration of solid lipid nanoparticles (SLNs) of artemether than the oral route. In conclusion, the intranasal administration of lipid nanoparticles of artemether could provide complete protection against cerebral malaria." @default.
• W2892070531 created "2018-09-27" @default.
• W2892070531 creator A5020013661 @default.
• W2892070531 creator A5028960835 @default.
• W2892070531 creator A5041587129 @default.
• W2892070531 creator A5081029365 @default.
• W2892070531 date "2018-09-01" @default.
• W2892070531 modified "2023-10-16" @default.
• W2892070531 title "INTRANASAL DELIVERY OF ARTEMETHER FOR THE TREATMENT OF CEREBRAL MALARIA" @default.
• W2892070531 cites W1889204973 @default.
• W2892070531 cites W1968427961 @default.
• W2892070531 cites W1981320103 @default.
• W2892070531 cites W1992986348 @default.
• W2892070531 cites W2017735077 @default.
• W2892070531 cites W2020415247 @default.
• W2892070531 cites W2022343786 @default.
• W2892070531 cites W2033980704 @default.
• W2892070531 cites W2041625419 @default.
• W2892070531 cites W2046002279 @default.
• W2892070531 cites W2052416553 @default.
• W2892070531 cites W2073056433 @default.
• W2892070531 cites W2082799656 @default.
• W2892070531 cites W2121836743 @default.
• W2892070531 cites W2122167407 @default.
• W2892070531 cites W2134349585 @default.
• W2892070531 cites W2142178060 @default.
• W2892070531 cites W2142404968 @default.
• W2892070531 cites W2612124957 @default.
• W2892070531 cites W2618801462 @default.
• W2892070531 cites W2775238672 @default.
• W2892070531 doi "https://doi.org/10.22159/ijpps.2018v10i9.25408" @default.
• W2892070531 hasPublicationYear "2018" @default.
• W2892070531 type Work @default.
• W2892070531 sameAs 2892070531 @default.
• W2892070531 citedByCount "3" @default.
• W2892070531 countsByYear W28920705312022 @default.
• W2892070531 countsByYear W28920705312023 @default.
• W2892070531 crossrefType "journal-article" @default.
• W2892070531 hasAuthorship W2892070531A5020013661 @default.
• W2892070531 hasAuthorship W2892070531A5028960835 @default.
• W2892070531 hasAuthorship W2892070531A5041587129 @default.
• W2892070531 hasAuthorship W2892070531A5081029365 @default.
• W2892070531 hasBestOaLocation W28920705311 @default.
• W2892070531 hasConcept C112705442 @default.
• W2892070531 hasConcept C11432220 @default.
• W2892070531 hasConcept C147789679 @default.
• W2892070531 hasConcept C150903083 @default.
• W2892070531 hasConcept C155672457 @default.
• W2892070531 hasConcept C171250308 @default.
• W2892070531 hasConcept C178790620 @default.
• W2892070531 hasConcept C185592680 @default.
• W2892070531 hasConcept C187530423 @default.
• W2892070531 hasConcept C192562407 @default.
• W2892070531 hasConcept C199529486 @default.
• W2892070531 hasConcept C203014093 @default.
• W2892070531 hasConcept C207001950 @default.
• W2892070531 hasConcept C22979827 @default.
• W2892070531 hasConcept C2776120307 @default.
• W2892070531 hasConcept C2778048844 @default.
• W2892070531 hasConcept C2778118209 @default.
• W2892070531 hasConcept C2778371730 @default.
• W2892070531 hasConcept C2779820397 @default.
• W2892070531 hasConcept C43617362 @default.
• W2892070531 hasConcept C71924100 @default.
• W2892070531 hasConcept C85663871 @default.
• W2892070531 hasConcept C86181022 @default.
• W2892070531 hasConcept C86803240 @default.
• W2892070531 hasConcept C98274493 @default.
• W2892070531 hasConceptScore W2892070531C112705442 @default.
• W2892070531 hasConceptScore W2892070531C11432220 @default.
• W2892070531 hasConceptScore W2892070531C147789679 @default.
• W2892070531 hasConceptScore W2892070531C150903083 @default.
• W2892070531 hasConceptScore W2892070531C155672457 @default.
• W2892070531 hasConceptScore W2892070531C171250308 @default.
• W2892070531 hasConceptScore W2892070531C178790620 @default.
• W2892070531 hasConceptScore W2892070531C185592680 @default.
• W2892070531 hasConceptScore W2892070531C187530423 @default.
• W2892070531 hasConceptScore W2892070531C192562407 @default.
• W2892070531 hasConceptScore W2892070531C199529486 @default.
• W2892070531 hasConceptScore W2892070531C203014093 @default.
• W2892070531 hasConceptScore W2892070531C207001950 @default.
• W2892070531 hasConceptScore W2892070531C22979827 @default.
• W2892070531 hasConceptScore W2892070531C2776120307 @default.
• W2892070531 hasConceptScore W2892070531C2778048844 @default.
• W2892070531 hasConceptScore W2892070531C2778118209 @default.
• W2892070531 hasConceptScore W2892070531C2778371730 @default.
• W2892070531 hasConceptScore W2892070531C2779820397 @default.
• W2892070531 hasConceptScore W2892070531C43617362 @default.
• W2892070531 hasConceptScore W2892070531C71924100 @default.
• W2892070531 hasConceptScore W2892070531C85663871 @default.
• W2892070531 hasConceptScore W2892070531C86181022 @default.
• W2892070531 hasConceptScore W2892070531C86803240 @default.
• W2892070531 hasConceptScore W2892070531C98274493 @default.
• W2892070531 hasIssue "9" @default.
• W2892070531 hasLocation W28920705311 @default.
• W2892070531 hasOpenAccess W2892070531 @default.
• W2892070531 hasPrimaryLocation W28920705311 @default.
• W2892070531 hasRelatedWork W1988156495 @default.

• next